APA (7th ed.) Citation

N, E., JB, D., ADM, K., & ML, C. (2026). Optimizing On-Demand Tenofovir Disoproxil Fumarate/Emtricitabine Dosing in Women for HIV Prevention. The Journal of infectious diseases, 233(2), 257. https://doi.org/10.1093/infdis/jiaf459

Chicago Style (17th ed.) Citation

N, Engel, Dumond JB, Kashuba ADM, and Cottrell ML. "Optimizing On-Demand Tenofovir Disoproxil Fumarate/Emtricitabine Dosing in Women for HIV Prevention." The Journal of Infectious Diseases 233, no. 2 (2026): 257. https://doi.org/10.1093/infdis/jiaf459.

MLA (9th ed.) Citation

N, Engel, et al. "Optimizing On-Demand Tenofovir Disoproxil Fumarate/Emtricitabine Dosing in Women for HIV Prevention." The Journal of Infectious Diseases, vol. 233, no. 2, 2026, p. 257, https://doi.org/10.1093/infdis/jiaf459.